Azoulay teaches courses on strategy and technology strategy at MIT Sloan. Previously, he was an associate professor of management at Columbia University’s Graduate School of Business. His research centers on how organizational design and social networks influence the productivity of research and development in the healthcare sector. Currently, Azoulay is studying the impact of superstar researchers on the research productivity of their colleagues in the academic life sciences. He also is interested in the topic of academic entrepreneurship, having recently concluded a major study of the antecedents and consequences of academic patenting. In the past, he has investigated the outsourcing strategies of pharmaceutical firms, in particular the role played by contract research organizations in the clinical trials process. He is a faculty Research Fellow at the National Bureau of Economic Research.
Azoulay holds a Diplôme D’études Supérieures de Gestion from the Institut National des Télécommunications, an MA in telecommunications from Michigan State University, and a PhD in management from the MIT Sloan School of Management
Platforms are what our friend Pierre Azoulay, an economist at MIT’s Sloan School of Management, calls “the internet of things your mom won’t do for you anymore.”
MIT Sloan's Pierre Azoulay takes a broad, conceptual view of how CUs need to embrace technology to drive innovation and market success.
A provocative new study by two biologists appears at first glance to highlight a worrisome paradox: As the nation's investment in the science that underlies new therapies has increased over the...
New study shows publicly funded research spurs private drug development.
A new study co-authored by an MIT economist reports that high-status authorship increases how frequently papers are cited in the life sciences but finds some subtle twists in how this happens. "We...
The president’s proposal has far-reaching implications for public health, research and drug development, and keeping America at the forefront of innovation.
Research measures “citation penalty” for authors of recanted work.
Pierre Azoulay, an economist at MIT Sloan, studies how life scientists work—or, more precisely, what makes them work well.
Attention, star scientists: Pierre Azoulay is watching you. Not literally, of course: Azoulay, an economist, inhabits an office tucked away in the MIT Sloan School of Management, far from any lab....
Retractions, with a twist: Even valid older research, when intellectually related to a retracted study, loses credibility—especially if the retracted paper involves malfeasance. The fallout from...
Advanced Management Program
Developing and Managing a Successful Technology Strategy
Systematic Innovation of Products, Processes, and Services
Platform Strategy: Building and Thriving in a Vibrant Ecosystem
Pierre Azoulay on Platform Strategy: Building and Thriving in a Vibrant Ecosystem.
Sign Up for Email Updates on Executive Education Programs